Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-465-2 | CAS number: 8047-99-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Local Lymph Node Assay (LLNA) (OECDTG 429): non-sensitizing (read across from p-Toluenesulfonamide CAS 70-55-3)
Guinea pig maximization test (GPMT) (OECDTG 406): non-sensitizing (read across from N-Ethyltoluene-2-sulfonamide CAS 10-77-56-1)
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Information is derived from an analogue
- Justification for type of information:
- The full read across justification report is attached under "Attached justification".
Summary
Within REACH, the obligation to conduct tests with vertebrate animals should be considered as a last resort, only after exhausting all potential sources of information on the physical and (eco)toxicological properties of chemicals [1].
Article 13 of REACH requires that use must be made whenever possible by alternatives to vertebrate animal tests, through the use of alternative methods as in vitro methods, (Q)SARs or from structurally related substances via grouping or read-across.
Annex XI of REACH offers the option to evaluate specific endpoints by read-across. According to Chapter R.6 (QSARs and grouping of chemicals) of REACH technical guidance documents (TGD), read-across can be applied for “substances whose physico-chemical, toxicological and ecotoxicological properties are likely to be similar or follow a regular pattern as a result of structural similarity”. Application of the read-across concept requires that physico-chemical properties, human health effects and environmental effects or environmental fate may be predicted from data from a reference substance to make a prediction of the endpoint for the target chemical. This avoids the need to test every substance for every endpoint. This report provides the justification to use a cross-reading approach between Toluenesulfonamides (p-Toluenesulfonamide (p-TSA, CAS 70-55-3), o-Toluenesulfonamide (o-TSA, CAS 88-19-7) and o/p-Toluenesulfonamide (o/p-TSA, CAS 1333 07 9)) and is presented according to the requirements stipulated in Chapter R.6 (QSARs and grouping of chemicals) of the REACH TGD for N-ethyl-o(or p)-toluenesulfonamide (NETSA, CAS 8047-99-2).
1. Regulation (EC) No 1907/2006 of the European Parliament and of the Council. Off. J. Eur. Union: 1–849 - Reason / purpose for cross-reference:
- read-across source
- Positive control results:
- The stimulation index of Hexyl Cinnamic Aldehyde (25% in vehicle v/v) was 4.42.
- Key result
- Parameter:
- SI
- Value:
- 1.23
- Test group / Remarks:
- Concentration (% w/v): 50
- Remarks on result:
- other: SI was < 3 / up to concentrations of 50% p-Toluenesulfonamide tested / no dose response relationship
- Parameter:
- SI
- Value:
- 1.48
- Test group / Remarks:
- Concentration (% w/v): 25
- Parameter:
- SI
- Value:
- 2.97
- Test group / Remarks:
- Concentration (% w/v): 10
- Parameter:
- SI
- Value:
- 1
- Test group / Remarks:
- Concentration (% w/v): 0
- Interpretation of results:
- not sensitising
- Remarks:
- in accordance with EU CLP (EC 1272/2008 and its updates).
- Conclusions:
- Under the experimental conditions of this study, p-Toluenesulfonamide did not have a skin sensitising potential when dermally applied up to concentrations of 50%. These results were used for read-across to N-ethyl-o (or p)-toluenesulfonamide.
- Executive summary:
In a GLP-compliant OECD Guideline 429 study, skin sensitisation properties of p-Toluenesulfonamide were studied in mice. Three test groups of 4 female mice each were treated with 10, 25, and 50% w/v by means of open application of 25 μL to the dorsum of each ear (total 50µL) for three consecutive days. Three days after the last treatment, all animals received an intravenous injection of 3H-thymidine. Five hours later, the 3H-thymidine incorporation in the draining auricular lymph nodes was determined. The results were compared with those of a negative control group which was treated with the vehicle (acetone/olive oil, 4:1 v/v). Group mean 3H-thymidine incorporations of 4974, 2473 and 2063 DPM were found in the auricular lymph nodes of animals treated with respectively 10, 25, and 50% p-Toluenesulfonamide. The group mean value in the vehicle control animals was 1672 DPM. The calculated stimulation indices (SI), representative of the change in 3H-thymidine incorporation in p-Toluenesulfonamide treated animals compared to controls, were 2.97, 1.48 and 1.23 for the tested doses of 10, 25, and 50% p-Toluenesulfonamide, respectively. Since the SI was < 3, the limiting value required for classification as a skin sensitiser, in response to all concentrations of p-Toluenesulfonamide tested and no dose response relationship was apparent it was concluded that p-Toluenesulfonamide did not have a skin sensitising potential when dermally applied up to concentrations of 50%.
These results were used for read-across to N-ethyl-o (or p)-toluenesulfonamide (NETSA).
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 24-29 Oct 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant, guideline study, available as unpublished report, no restrictions, fully adequate for assessment
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- TNO Triskelion, Utrechtseweg 48 3704 HE Zeist, the Netherlands
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories
- Age at study initiation: approximately 9-11 weeks
- Weight at study initiation: 21.1 - 25.5 g
- Housing: During acclimatisation the animals were group housed in macrolon type III cages (maximally 5 mice/cage). After allocation the animals were housed in macrolon type III cages (4 mice/group/cage) for the main study. For the dose range finding test, one animal was housed in a macrolon type II cage. The cages were provided with wood shavings (Lignocel) as bedding material and shreds of paper (Enviro-dri) and gnaw wood as environmental enrichment
- Diet: Standard diet ad libitum (Rat and Mouse no.3 breeding diet RM3) was purchased from SDS Special Diets Services, Whitham, England.
- Water: domestic mains tap-water, ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2, one deviation from the optimal temperature was observed (period of <30 minutes of 24.7°C).
- Humidity (%): 45-65, the actual upper limit during the study period was 99.9%, which was considered not to have affected study integrity.
- Air changes (per hr): ca 10
- Photoperiod (hrs dark / hrs light): 12/12 (light on from 7:00 AM - 7:00 PM) - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 0, 10, 25, 50% w/v
- No. of animals per dose:
- 4
- Details on study design:
- DOSE FORMULATIONS:
The dose formulations of the test substance in vehicle were freshly prepared on each day of dosing, i.e. day 0, 1 and 2. The formulation was prepared on a weight (test substance)/volume (vehicle) basis. The formulation was mixed (vortex) until visible homogeneity was obtained. Based on known hazard data of p-Toluenesulfonamide it was to be expected that dermal application of a 50% (and lower) concentration should not cause systemic toxicity and/or excessive skin irritation. Therefore, concentrations of 50%, 25% and 10% were selected for this study. No adjustment was made for the purity of the test substance. The dose formulations were used for dosing of the animals within 2 hours after preparation. Homogeneity, concentration and stability of the test substance in vehicle were not determined in this study.
STUDY DESIGN:
On day 0, 1 and 2 the different concentrations of test substance and control substances were administered to the dorsum of both ears (25 μL on each ear by means of a pipette). On day 5 all animals received an intravenous injection of 250 μL of phosphate-buffered saline (PBS) containing 20 μCi of 3H-thymidine in the tail vein. Five hours after the 3H-thymidine injection the animals were sacrificed by intra peritoneal (i.p.) injection with an overdose of sodium pentobarbital and the draining auricular lymph nodes were excised, pooled per animal in PBS and further processed to determine the 3H-thymidine incorporation. Per animal, the paired auricular lymph nodes (ALN) were excised and were placed together in a vial containing 5 mL phosphate buffered solution (PBS). A single cell suspension was prepared by gently rubbing the nodes between the rough ends of microscope slides. The cell suspension was washed twice. The cell pellet obtained after the second wash was resuspended in 3 mL of 5% trichloroacetic acid (TCA) and left overnight (~18 hours) at 2-10ºC. After centrifugation and removal of the supernatant, 1 mL of 1.5 M KOH in 20% EtOH was added to the precipitate and left for 24 hours at room temperature. Thereafter, the solution was transferred into a clean scintillation vial and 20 mL liquid scintillation cocktail (Hionic Fluor, Perkin Elmer) was added. The vial was thoroughly shaken and the number of disintegrations per minute (DPM) was determined by counting for five minutes in a liquid scintillation counter (Perkin Elmer).
OBSERVATIONS:
The general condition and behaviour of the animals were checked at least once daily during the study. All findings including any abnormalities were recorded in the morning, when applicable before dosing and in case of changes in clinical signs also in the afternoon. Body weights were determined at allocation, at the start (day 0) and at the end (day 5) of the study. The animals were sacrificed on day 5 for excision of the auricular lymph nodes. The animals were macroscopically examined including the auricular lymph nodes and the ears. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Statistical evaluation of the data (body weights and 3H-thymidine incorporation) were performed by one-way ANOVA, followed by Dunnett’s multiple comparison tests in case of a significant result. In case of difference of variance between the different groups, log-transformation of the data before statistical evaluation was considered. Body weights and 3H-thymidine incorporation of the test groups or the positive control group were compared with the vehicle control animals. Probability values of p<0.05 were considered significant.
- Positive control results:
- The stimulation index of Hexyl Cinnamic Aldehyde (25% in vehicle v/v) was 4.42.
- Key result
- Parameter:
- SI
- Value:
- 1.23
- Test group / Remarks:
- Concentration (% w/v): 50
- Remarks on result:
- other: SI was < 3 / up to concentrations of 50% p-Toluenesulfonamide tested / no dose response relationship
- Parameter:
- SI
- Value:
- 1.48
- Test group / Remarks:
- Concentration (% w/v): 25
- Parameter:
- SI
- Value:
- 2.97
- Test group / Remarks:
- Concentration (% w/v): 10
- Parameter:
- SI
- Value:
- 1
- Test group / Remarks:
- Concentration (% w/v): 0
- Cellular proliferation data / Observations:
- SI was < 3 / up to concentrations of 50% p-Toluenesulfonamide tested / no dose response relationship
- Interpretation of results:
- not sensitising
- Remarks:
- in accordance with EU CLP (EC 1272/2008 and its updates).
- Conclusions:
- Under the experimental conditions of this study, p-Toluenesulfonamide did not have a skin sensitising potential when dermally applied up to concentrations of 50%. These results were used for read-across to N-Ethyl-o (or p)-toluenesulfonamide (NETSA).
- Executive summary:
In a GLP-compliant OECD Guideline 429 study, skin sensitisation properties of p-Toluenesulfonamide were studied in mice. Three test groups of 4 female mice each were treated with 10, 25, and 50% w/v by means of open application of 25 μL to the dorsum of each ear (total 50µL) for three consecutive days. Three days after the last treatment, all animals received an intravenous injection of 3H-thymidine. Five hours later, the 3H-thymidine incorporation in the draining auricular lymph nodes was determined. The results were compared with those of a negative control group which was treated with the vehicle (acetone/olive oil, 4:1 v/v). Group mean 3H-thymidine incorporations of 4974, 2473 and 2063 DPM were found in the auricular lymph nodes of animals treated with respectively 10, 25, and 50% p-Toluenesulfonamide. The group mean value in the vehicle control animals was 1672 DPM. The calculated stimulation indices (SI), representative of the change in 3H-thymidine incorporation in p-Toluenesulfonamide treated animals compared to controls, were 2.97, 1.48 and 1.23 for the tested doses of 10, 25, and 50% p-Toluenesulfonamide, respectively. Since the SI was < 3, the limiting value required for classification as a skin sensitiser, in response to all concentrations of p-Toluenesulfonamide tested and no dose response relationship was apparent it was concluded that p-Toluenesulfonamide did not have a skin sensitising potential when dermally applied up to concentrations of 50%.
These results were used for read-across to N-ethyl-o (or p)-toluenesulfonamide (NETSA).
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Information is derived from an analogue
- Justification for type of information:
- The full read across justification report is attached under "Attached justification".
Summary
Within REACH, the obligation to conduct tests with vertebrate animals should be considered as a last resort, only after exhausting all potential sources of information on the physical and (eco)toxicological properties of chemicals [1].
Article 13 of REACH requires that use must be made whenever possible by alternatives to vertebrate animal tests, through the use of alternative methods as in vitro methods, (Q)SARs or from structurally related substances via grouping or read-across.
Annex XI of REACH offers the option to evaluate specific endpoints by read-across. According to Chapter R.6 (QSARs and grouping of chemicals) of REACH technical guidance documents (TGD), read-across can be applied for “substances whose physico-chemical, toxicological and ecotoxicological properties are likely to be similar or follow a regular pattern as a result of structural similarity”. Application of the read-across concept requires that physico-chemical properties, human health effects and environmental effects or environmental fate may be predicted from data from a reference substance to make a prediction of the endpoint for the target chemical. This avoids the need to test every substance for every endpoint. This report provides the justification to use a cross-reading approach between Toluenesulfonamides (p-Toluenesulfonamide (p-TSA, CAS 70-55-3), o-Toluenesulfonamide (o-TSA, CAS 88-19-7) and o/p-Toluenesulfonamide (o/p-TSA, CAS 1333 07 9)) and is presented according to the requirements stipulated in Chapter R.6 (QSARs and grouping of chemicals) of the REACH TGD for N-ethyl-o(or p)-toluenesulfonamide (NETSA, CAS 8047-99-2).
1. Regulation (EC) No 1907/2006 of the European Parliament and of the Council. Off. J. Eur. Union: 1–849 - Reason / purpose for cross-reference:
- read-across source
- Key result
- Reading:
- other: not specified
- Group:
- test chemical
- Dose level:
- not specified
- Remarks on result:
- no indication of skin sensitisation
- Interpretation of results:
- other: not skin sensitisng
- Remarks:
- in accordance with EU CLP (EC 1272/2008 and its updates).
- Conclusions:
- One of the GPMT tests was performed with Ethyl toluene sulfonamide according to the Magnusson and Klingman method. Under the conditions of the test, it was concluded that Ethyl toluene sulfonamide was not skin sensitising. These results were used for read-across to N-ethyl-o (or p)-toluenesulfonamide.
- Executive summary:
Enstein et al. (1997) developed a quantitative structure-toxicity relationship model (QSTR) for assessing dermal sensitization using guinea pig maximization test (GPMT) results.The QSTR models were derived from 315 evaluated chemicals.One of the GPMT tests was performed with Ethyl toluene sulfonamide according to the Magnusson and Klingman method. Under the conditions of the test, it was concluded that Ethyl toluene sulfonamide was not skin sensitising.
These results were used for read-across to N-ethyl-o (or p)-toluenesulfonamide (NETSA).
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 1997
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study without detailed documentation
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- GLP compliance:
- not specified
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Existing in vivo data were used. Published in 1997 and the GPMT was performed latest 1997.
- Specific details on test material used for the study:
- Ethyl toluene sulfonamide (CAS 1077-56-1)
- Species:
- guinea pig
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 250 - 500 g
ENVIRONMENTAL CONDITIONS
not specified - Route:
- intradermal and epicutaneous
- Vehicle:
- not specified
- Concentration / amount:
- The highest to cause mild-to-moderate skin irritation
- Day(s)/duration:
- Ca. day 0 - 8
- Adequacy of induction:
- not specified
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- not specified
- Concentration / amount:
- the highest non-irritant dose
- Day(s)/duration:
- ca. day 20 - 22
- Adequacy of challenge:
- not specified
- No. of animals per dose:
- 15- 20
- Positive control substance(s):
- not specified
- Key result
- Reading:
- other: not specified
- Group:
- test chemical
- Dose level:
- not specified
- Remarks on result:
- no indication of skin sensitisation
- Interpretation of results:
- other: not skin sensitisng
- Remarks:
- in accordance with EU CLP (EC 1272/2008 and its updates)
- Conclusions:
- One of the GPMT tests was performed with Ethyl toluene sulfonamide according to the Magnusson and Klingman method. Under the conditions of the test, it was concluded that Ethyl toluene sulfonamide was not skin sensitising.These results were used for read-across to N-ethyl-o (or p)-toluenesulfonamide.
- Executive summary:
Enstein et al. (1997) developed a quantitative structure-toxicity relationship model (QSTR) for assessing dermal sensitization using guinea pig maximization test (GPMT) results.The QSTR models were derived from 315 evaluated chemicals.One of the GPMT tests was performed with Ethyl toluene sulfonamide according to the Magnusson and Klingman method. Under the conditions of the test, it was concluded that Ethyl toluene sulfonamide was not skin sensitising.
These results were used for read-across to N-ethyl-o (or p)-toluenesulfonamide (NETSA).
Referenceopen allclose all
No signs of local irritation or clinical signs of systemic toxicity were observed in any of the animals during the study period. No aberrant body weights or body weight gains were observed and no statistical significant difference was found between the vehicle and the different test groups and between the vehicle and the positive control group.
The cross-validated specificity of the equations range between 81 and 91% and the sensitivity between 85 and 95% for the dataset. For an independent test set, specificity us 79% and sensitivity is 82%.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
Local Lymph Node Assay (LLNA) (OECDTG 429):
In a GLP-compliant OECD Guideline 429 study, skin sensitisation properties of p-Toluenesulfonamide were studied in mice. Three test groups of 4 female mice each were treated with 10, 25, and 50% w/v by means of open application of 25 μL to the dorsum of each ear (total 50µL) for three consecutive days. Three days after the last treatment, all animals received an intravenous injection of 3H-thymidine. Five hours later, the 3H-thymidine incorporation in the draining auricular lymph nodes was determined. The results were compared with those of a negative control group which was treated with the vehicle (acetone/olive oil, 4:1 v/v). Group mean 3H-thymidine incorporations of 4974, 2473 and 2063 DPM were found in the auricular lymph nodes of animals treated with respectively 10, 25, and 50% p-Toluenesulfonamide. The group mean value in the vehicle control animals was 1672 DPM. The calculated stimulation indices (SI), representative of the change in 3H-thymidine incorporation in p-Toluenesulfonamide treated animals compared to controls, were 2.97, 1.48 and 1.23 for the tested doses of 10, 25, and 50% p-Toluenesulfonamide, respectively. Since the SI was < 3, the limiting value required for classification as a skin sensitiser, in response to all concentrations of p-Toluenesulfonamide tested and no dose response relationship was apparent it was concluded that p-Toluenesulfonamide did not have a skin sensitising potential when dermally applied up to concentrations of 50%. This result was used for read-across to N-ethyl-o/p-toluene sulphonamide (NETSA).
Guinea pig maximization test (GPMT) (OECDTG 406)
Enstein et al. (1997) developed a quantitative structure-toxicity relationship model (QSTR) for assessing dermal sensitization using guinea pig maximization test (GPMT) results.The QSTR models were derived from 315 evaluated chemicals.One of the GPMT tests was performed with Ethyl toluene sulfonamide according to the Magnusson and Klingman method. Under the conditions of the test, it was concluded that Ethyl toluene sulfonamide was not skin sensitising.This result is used for read-across to N-ethyl-o/p-toluenesulphonamide (NETSA).
Justification for classification or non-classification
Based on the information available via read-across, to substance N-Ethyl-o (or p)-toluenesulfonamide (NETSA) does not have to be classified as skin sensitizer in accordance with the criteria outlined in Annex 1 of the CLP Regulation (1272/2008/EC).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.